New oral biologic MB-001 passes early safety check in healthy people
Disease control
Completed
This early-stage study tested whether an oral biologic drug called MB-001 is safe in 48 healthy adults. Participants received either a single dose or five daily doses of the drug or a placebo, and stayed in the clinic for five days after the last dose. The main goal was to check …
Phase: PHASE1 • Sponsor: Mage Biologics • Aim: Disease control
Last updated May 08, 2026 12:01 UTC